OpGen, Inc. (OPGN)

Market Cap	14.62M
Revenue (ttm)	1.96M
Net Income (ttm)	-22.39M
Shares Out	8.36M
EPS (ttm)	-19.09
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	250
Open	1.750
Previous Close	1.750
Day's Range	1.750 - 1.820
52-Week Range	1.610 - 9.900
Beta	-0.66
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 19, 2024

About OpGen

OpGen, Inc., a precision medicine company, develops and commercializes molecular microbiology solutions for life threatening infectious diseases in the United States and internationally. The company’s products include Unyvero application cartridges, Unyvero systems, Acuitas AMR Gene Panel test products, and SARS CoV-2 test kits. It provides laboratory services; collaboration services, including funded software arrangements; and license arrangements services. OpGen, Inc. was incorporated in 2001 and is headquartered in Rockville, Maryland.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2001
• Employees: 93
• Stock Exchange: OTCMKTS
• Ticker Symbol: OPGN

Financial Performance

In 2023, OpGen's revenue was $3.42 million, an increase of 31.11% compared to the previous year's $2.61 million. Losses were -$32.67 million, -12.38% less than in 2022.